» Articles » PMID: 38521876

1,2,3-triazole and Chiral Schiff Base Hybrids As Potential Anticancer Agents: DFT, Molecular Docking and ADME Studies

Overview
Journal Sci Rep
Specialty Science
Date 2024 Mar 24
PMID 38521876
Authors
Affiliations
Soon will be listed here.
Abstract

A series of novel 1,2,3-triazole and chiral Schiff base hybrids 2-6 were synthesized by Schiff base condensation reaction from pre-prepared parent component of the hybrids (1,2,3-triazole 1) and series of primary chiral amines and their chemical structure were confirmed using NMR and FTIR spectroscopies, and CHN elemental analysis. Compounds 1-6 were evaluated for their anticancer activity against two cancer PC3 (prostate) and A375 (skin) and MRC-5 (healthy) cell lines by Almar Blue assay method. The compounds exhibited significant cytotoxicity against the tested cancer cell lines. Among the tested compounds 3 and 6 showed very good activity for the inhibition of the cancer cell lines and low toxicity for the healthy cell lines. All the compounds exhibited high binding affinity for Androgen receptor modulators (PDB ID: 5t8e) and Human MIA (PDB ID: 1i1j) inhibitors compared to the reference anticancer drug (cisplatin). Structure activity relationships (SARs) of the tested compounds is in good agreement with DFT and molecular docking studies. The compounds exhibited desirable physicochemical properties for drug likeness.

Citing Articles

Aniline Derivatives Containing 1-Substituted 1,2,3-Triazole System as Potential Drug Candidates: Pharmacokinetic Profile Prediction, Lipophilicity Analysis Using Experimental and In Silico Studies.

Chrobak E, Bober-Majnusz K, Wyszomirski M, Zieba A Pharmaceuticals (Basel). 2024; 17(11).

PMID: 39598388 PMC: 11597839. DOI: 10.3390/ph17111476.


Schiff Bases Derived from Pyridoxal 5'-Phosphate and 2-X-Phenylamine (X = H, OH, SH): Substituent Effects on UV-Vis Spectra and Hydrolysis Kinetics.

Zavalishin M, Kiselev A, Gamov G Molecules. 2024; 29(15).

PMID: 39124909 PMC: 11314395. DOI: 10.3390/molecules29153504.


Synthesis, Docking, and Machine Learning Studies of Some Novel Quinolinesulfonamides-Triazole Hybrids with Anticancer Activity.

Marciniec K, Nowakowska J, Chrobak E, Bebenek E, Latocha M Molecules. 2024; 29(13).

PMID: 38999109 PMC: 11243625. DOI: 10.3390/molecules29133158.

References
1.
Swislocka R, Regulska E, Karpinska J, Swiderski G, Lewandowski W . Molecular Structure and Antioxidant Properties of Alkali Metal Salts of Rosmarinic Acid. Experimental and DFT Studies. Molecules. 2019; 24(14). PMC: 6680818. DOI: 10.3390/molecules24142645. View

2.
Adegoke R, Oyebamiji A, Semire B . Dataset on the DFT-QSAR, and docking approaches for anticancer activities of 1, 2, 3-triazole-pyrimidine derivatives against human esophageal carcinoma (EC-109). Data Brief. 2020; 31:105963. PMC: 7365971. DOI: 10.1016/j.dib.2020.105963. View

3.
Yadav P, Lal K, Kumar A, Guru S, Jaglan S, Bhushan S . Green synthesis and anticancer potential of chalcone linked-1,2,3-triazoles. Eur J Med Chem. 2016; 126:944-953. DOI: 10.1016/j.ejmech.2016.11.030. View

4.
Bonandi E, Christodoulou M, Fumagalli G, Perdicchia D, Rastelli G, Passarella D . The 1,2,3-triazole ring as a bioisostere in medicinal chemistry. Drug Discov Today. 2017; 22(10):1572-1581. DOI: 10.1016/j.drudis.2017.05.014. View

5.
Wu X, Liu L, Wang Q, Wang H, Zhao X, Lin X . Antitumor Activity and Mechanism Study of Riluzole and Its Derivatives. Iran J Pharm Res. 2021; 19(3):217-230. PMC: 7757987. DOI: 10.22037/ijpr.2020.1101149. View